DONALD J. KELLERMAN - 31 Mar 2022 Form 4 Insider Report for Zosano Pharma Corp

Role
VP, Clinical Dev & Med Affairs
Signature
/s/ Steven Lo, Attorney-in-Fact for Donald J. Kellerman
Issuer symbol
N/A
Transactions as of
31 Mar 2022
Net transactions value
-$842
Form type
4
Filing time
01 Apr 2022, 21:08:14 UTC
Previous filing
19 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZSAN Common Stock Sale $842 -4,006 -6.6% $0.2101* 56,331 31 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to restricted stock units of the Issuer.